Moreover, CD44 expression of almost all the NSCLC cell lines, but not the CD44 negative SCLC cell line, decreased at least twofold at the molecular surface level after treating the cells with MβCD and Simva (Fig. 6). This evidence concerns the gene CD44 and small cell lung carcinoma.